New Delhi | Central drug regulator CDSCO has initiated risk-based inspection of drug manufacturing units in six states following collection of 19 samples including that of cough syrups, antipyretics ...

Planning to outsource GMP audits to agencies certified by QCI; onboard 1,500 experts to review drug applications ...